I think this AIM-listed tech stock is beginning to fulfil its potential

Blue Prism is an RPA specialist that has just revealed a chunky loss. But look closer, I think it’s misunderstood by the markets.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Blue Prism (LSE: PRSM) is a company operating in the intelligent automation, or robotic process automation (RPA), space. It has just revealed a chunky loss but if we look closer, I think it’s misunderstood by the markets.

It all boils down to recurring revenue and to illustrate that, I’ll use  an analogy with an old-fashioned life assurance salesperson. It might take a lot to secure a new customer, but once that’s achieved, the salesperson can enjoy the commission for years. Blue Prism has been spending a lot on marketing, that’s the main reason why 2019 saw a big loss. But the revenue that will accrue from new business acquisition could continue for years.

Blue Prism invented the acronym RPA that actually has very little to do with what most of us think of when we hear the word robot. RPA is actually about software and automating tasks, often mind-numbingly dull tasks, often carried out in process-driven organisations such as banks or insurance companies.

RPA has been subject to enormous hype and some backlash too. It’s not necessarily easy for a company to start on its RPA journey, and maybe some RPA companies have promoted the technology too hard, exaggerating its ease of use, creating a degree of disillusionment.

There’s even talk that the RPA industry may actually ditch the acronym altogether to focus on intelligent automation.

Hype?

Blue Prism is the only one of the three major RPA companies to be listed on the stock market. The other two (UiPath and Automation Anywhere) have collectively raised well over a billion dollars.

Such massive fund raising is seen by some as evidence of hype, but it also illustrates how there’s something exciting about the technology in the first place.

It could certainly transform productivity at many companies. Some fear resulting job losses, but the RPA companies themselves talk about freeing staff from soul-destroying tedium.

Blue Prism’s results for the year to the end of October 2019 revealed an 83% increase in revenues to £101m, but its losses before interest, tax, depreciation and amortisation (EBITDA) were £71.9m. Then again, it had £74.1m in net cash at the end of the period. 

A loss of that scale might seem worrisome, but bear in mind the long-term benefits from its marketing spend. Monthly recurring revenue (MMR) rose to £10.6m, up roughly two-thirds from the year before.

Part of the loss was also explained by the purchase of another company in this space, Thoughtonomy, giving Blue Prism a stronger cloud presence.

What I like about RPA is that the ‘barriers to exit’ are quite low. Once a company is using a particular system, there’s a good chance it will stay with it. Certainly, client retention rates in this space are very high.

The Blue Prism customer count increased from 992 to 1,677 last year. New clients included Audi, Amazon, Bank of China, Consolidated Edison, the International Monetary Fund, L’Oréal and the United States Department of Justice.

The company expects to upsell its product to many of its customers, and it’s this scaling up of the technology within companies that provides the real opportunity to increase sales at a relatively modest cost. This is the reason why I think Blue Prism shares will go up, eventually.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Michael Baxter has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »